NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma

Background: Novel immune therapies targeting tumor specific antigens are being developed. Our purpose was to determine expression of the cancer testes antigen NY-ESO-1 in renal cell carcinoma (RCC), as NY-ESO-1 targeting approaches, particularly adoptive cell therapy, have not been evaluated in this...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Giesen, Eva, Jilaveanu, Lucia B., Parisi, Fabio, Kluger, Yuval, Camp, Robert L., Kluger, Harriet M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2014
Gaiak:
Clinical Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4170640/
https://ncbi.nlm.nih.gov/pubmed/24970819
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak